SEC Form SC 13G filed by UL Solutions Inc.

11/8/24 1:08:21 PM ET

$ULS

Precision Instruments

Health Care

Get the next $ULS alert in real time by email

SC 13G 1 sc13g.htm SCHEDULE 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

UL Solutions Inc.

(Name of Issuer)

Class A common stock, par value $0.001 per share

(Title of Class of Securities)

903731107

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☐

Rule 13d-1(c)

☑

Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of the section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1	NAME OF REPORTING PERSON ULSE Inc.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 0
	6	SHARED VOTING POWER 138,130,000⁽¹⁾
	7	SOLE DISPOSITIVE POWER 0
	8	SHARED DISPOSITIVE POWER 138,130,000⁽¹⁾

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 138,130,000⁽¹⁾
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 69.06%⁽²⁾
12	TYPE OF REPORTING PERSON CO

⁽¹⁾

Reflects 138,130,000 shares of Class B common stock held directly by ULSE Inc., which are convertible at any time at the option of the holder into Class A common stock on a one-for-one basis. ULSE Inc. is managed by a board of directors consisting of Philip S. Khoury, James M. Shannon and Joel R. Wittenberg, none of whom, acting individually, has voting control or investment discretion with respect to the securities owned. Underwriters Laboratories Inc., a Delaware charitable nonstock corporation, is the sole member of ULSE Inc. Underwriters Laboratories Inc. is managed by a board of trustees consisting of James P. Dollive, Philip S. Khoury, Richard P. Owen, Darryll Pines, Mark Schmid, James M. Shannon, Elisabeth Tørstad and George A. Williams, none of whom, acting individually, has voting control or investment discretion with respect to the securities owned by ULSE Inc.

⁽²⁾

The percentage of Class A common stock is based on 61,876,949 shares of Class A common stock outstanding as of September 5, 2024, the date of effectiveness of the Issuer’s Registration Statement on Form S-1 (Registration 333-281902) filed with the Securities and Exchange Commission (the “SEC”) on September 3, 2024, plus 138,130,000 shares of Class A common stock issuable upon the conversion of Class B common stock.

1	NAME OF REPORTING PERSON Underwriters Laboratories Inc.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 0
	6	SHARED VOTING POWER 138,130,000⁽¹⁾
	7	SOLE DISPOSITIVE POWER 0
	8	SHARED DISPOSITIVE POWER 138,130,000⁽¹⁾

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 138,130,000⁽¹⁾
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 69.06%⁽²⁾
12	TYPE OF REPORTING PERSON CO

⁽¹⁾

⁽²⁾

Item 1(a)

Name of Issuer

The name of the issuer is UL Solutions Inc. (the “Issuer”).

Item 1(b)

Address of Issuer’s Principal Executive Offices

The Issuer’s principal executive offices are located at: 333 Pfingsten Rd., Northbrook, Illinois 60062.

Item 2(a)

Name of Person Filing

This statement is filed by the following (each hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons”):

(i)

ULSE Inc., a Delaware nonprofit nonstock corporation, which directly holds Class B common stock; and

(ii)

Underwriters Laboratories Inc., a Delaware charitable nonstock corporation, which is the sole member of ULSE Inc.

The Joint Filing Agreement among the Reporting Persons to file this Schedule 13G jointly in accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is filed as Exhibit A herein.

Item 2(b)

Address of Principal Business Office or, if None, Residence

The address of the business office of the Reporting Person is: 1603 Orrington Ave, Suite 2000, Evanston, Illinois 60201.

Item 2(c)

Citizenship

See Item 4 of each of the cover pages.

Item 2(d)

Title of Class of Securities

Class A common stock, par value $0.001 per share.

Item 2(e)

CUSIP No.

903731107

Item 3.

If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

Not Applicable.

Item 4.

Ownership

(a)

Amount Beneficially Owned: See Item 9 of each of the cover pages.

(b)

Percent of Class: See Item 11 of each of the cover pages.

(c)

Number of Shares as to which such person has:

(i)

Sole power to vote or direct the vote: See Item 5 of each of the cover pages.

(ii)

Shared power to vote or direct the vote: See Item 6 of each of the cover pages.

(iii)

Sole power to dispose or direct the disposition: See Item 7 of each of the cover pages.

(iv)

Shared power to dispose or direct the disposition: See Item 8 of each of the cover pages.

Item 5.

Ownership of Five Percent or Less of a Class

Not applicable.

Item 6.

Ownership of More Than Five Percent on Behalf of Another Person

Not applicable.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

Not applicable.

Item 8.

Identification and Classification of Members of the Group

Not applicable.

Item 9.

Notice of Dissolution of Group

Not applicable.

Item 10.

Certification

Not applicable.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 8, 2024

	ULSE Inc.

	By:	/s/ Ron H. Blaustein
		Name: Ron H. Blaustein
		Title: Senior Vice President and Chief Financial Officer

	Underwriters Laboratories Inc.

	By:	/s/ D. Michael Murray
		Name: D. Michael Murray
		Title: Vice President, Corporate and Legal Affairs

Get the next $ULS alert in real time by email

Date	Price Target	Rating	Analyst
10/7/2024	$60.00	Buy	Citigroup
7/12/2024	$41.00 → $46.00	Outperform → Neutral	Robert W. Baird

SEC Form SC 13G filed by UL Solutions Inc.

Chat with this insight

Recent Analyst Ratings for
$ULS

$ULS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Amendment: EVP & CCO Uggetti Alberto covered exercise/tax liability with 361 shares, decreasing direct ownership by 3% to 10,398 units (SEC Form 4)

Amendment: Officer Zhou Weifang covered exercise/tax liability with 3,809 shares, decreasing direct ownership by 8% to 43,652 units (SEC Form 4)

Amendment: Senior VP & CAO Pepping Karen K covered exercise/tax liability with 590 shares, decreasing direct ownership by 11% to 4,992 units (SEC Form 4)

$ULS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.